Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

ClinicalTrials.gov ID: NCT06529419

Public ClinicalTrials.gov record NCT06529419. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Dose Range-Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 Given Once Daily for 12 Weeks in Adults With Uncontrolled Asthma at Risk of Exacerbations (LEVANTE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A dose range-finding study to assess the efficacy and safety of multiple dose levels of AZD8630 administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA).

Study identification

NCT ID
NCT06529419
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
537 participants

Conditions and interventions

Conditions

Interventions

Drug · Device

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 29, 2024
Primary completion
Feb 3, 2026
Completion
Feb 3, 2026
Last update posted
Mar 1, 2026

2024 – 2026

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
44
Facility City State ZIP Site status
Research Site Mesa Arizona 85213
Research Site Huntington Beach California 92647
Research Site La Mesa California 91942
Research Site Laguna Niguel California 92677
Research Site Lancaster California 93534
Research Site Long Beach California 90815
Research Site San Jose California 95117
Research Site New Haven Connecticut 06510
Research Site DeBary Florida 32713
Research Site Jacksonville Florida 32216
Research Site Jensen Beach Florida 34957
Research Site Largo Florida 33777
Research Site Miami Florida 33135
Research Site Miami Lakes Florida 33014
Research Site Tampa Florida 33607
Research Site Lilburn Georgia 30047
Research Site Savannah Georgia 31406
Research Site Chicago Illinois 60616
Research Site Winfield Illinois 60190
Research Site Ames Iowa 50010
Research Site Kansas City Kansas 66160
Research Site Baltimore Maryland 21237
Research Site Methuen Massachusetts 01844
Research Site Ann Arbor Michigan 48109
Research Site Detroit Michigan 48202
Research Site Las Vegas Nevada 89102
Research Site Las Vegas Nevada 89119
Research Site Riverdale New Jersey 07457
Research Site Middletown New York 10941
Research Site Greenville North Carolina 27834
Research Site Winston-Salem North Carolina 27104
Research Site Beavercreek Ohio 45431
Research Site Lima Ohio 45801
Research Site Oklahoma City Oklahoma 73120
Research Site Horsham Pennsylvania 19044
Research Site Austin Texas 78704
Research Site McKinney Texas 75069
Research Site Mesquite Texas 75149
Research Site Pearland Texas 77584
Research Site San Antonio Texas 78215
Research Site American Fork Utah 84003
Research Site Roy Utah 84067
Research Site Salt Lake City Utah 84124
Research Site Hampton Virginia 23666
Research Site Milwaukee Wisconsin 53228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 151 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06529419, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 1, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06529419 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →